176 related articles for article (PubMed ID: 38364885)
21. Molecular and cellular characterizations of a cDNA clone encoding a novel isozyme of aldehyde dehydrogenase from rice.
Li Y; Nakazono M; Tsutsumi N; Hirai A
Gene; 2000 May; 249(1-2):67-74. PubMed ID: 10831839
[TBL] [Abstract][Full Text] [Related]
22. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
Ma Z; Jiang L; Li B; Liang D; Feng Y; Liu L; Jiang C
Bioorg Med Chem; 2021 Sep; 46():116352. PubMed ID: 34403955
[TBL] [Abstract][Full Text] [Related]
23. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
[TBL] [Abstract][Full Text] [Related]
24. Comparative and evolutionary studies of vertebrate ALDH1A-like genes and proteins.
Holmes RS
Chem Biol Interact; 2015 Jun; 234():4-11. PubMed ID: 25446856
[TBL] [Abstract][Full Text] [Related]
25. Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1.
Morgan CA; Hurley TD
Chem Biol Interact; 2015 Jun; 234():29-37. PubMed ID: 25450233
[TBL] [Abstract][Full Text] [Related]
26. Identification of approved drugs with ALDH1A1 inhibitory potential aimed at enhancing chemotherapy sensitivity in cancer cells: an in-silico drug repurposing approach.
Paul SK; Guendouzi A; Banerjee A; Guendouzi A; Haldar R
J Biomol Struct Dyn; 2024 Jan; ():1-15. PubMed ID: 38189344
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
Januchowski R; Wojtowicz K; Sterzyſska K; Sosiſska P; Andrzejewska M; Zawierucha P; Nowicki M; Zabel M
Int J Biochem Cell Biol; 2016 Sep; 78():248-259. PubMed ID: 27443528
[TBL] [Abstract][Full Text] [Related]
28. Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Chui MH; Wang Y; Wu RC; Seidman J; Kurman RJ; Wang TL; Shih IeM
Mod Pathol; 2015 Mar; 28(3):437-45. PubMed ID: 25216223
[TBL] [Abstract][Full Text] [Related]
29. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
[TBL] [Abstract][Full Text] [Related]
30. ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.
Kaipio K; Chen P; Roering P; Huhtinen K; Mikkonen P; Östling P; Lehtinen L; Mansuri N; Korpela T; Potdar S; Hynninen J; Auranen A; Grénman S; Wennerberg K; Hautaniemi S; Carpén O
J Pathol; 2020 Feb; 250(2):159-169. PubMed ID: 31595974
[TBL] [Abstract][Full Text] [Related]
31. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
Deng S; Yang X; Lassus H; Liang S; Kaur S; Ye Q; Li C; Wang LP; Roby KF; Orsulic S; Connolly DC; Zhang Y; Montone K; Bützow R; Coukos G; Zhang L
PLoS One; 2010 Apr; 5(4):e10277. PubMed ID: 20422001
[TBL] [Abstract][Full Text] [Related]
32. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
Morgan CA; Hurley TD
J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381
[TBL] [Abstract][Full Text] [Related]
33. Multiple machine learning models combined with virtual screening and molecular docking to identify selective human ALDH1A1 inhibitors.
Narendra G; Raju B; Verma H; Sapra B; Silakari O
J Mol Graph Model; 2021 Sep; 107():107950. PubMed ID: 34089986
[TBL] [Abstract][Full Text] [Related]
34. Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
Roy M; Connor J; Al-Niaimi A; Rose SL; Mahajan A
Hum Pathol; 2018 Mar; 73():1-6. PubMed ID: 28851663
[TBL] [Abstract][Full Text] [Related]
35. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.
Parajuli B; Georgiadis TM; Fishel ML; Hurley TD
Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340
[TBL] [Abstract][Full Text] [Related]
36. Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.
Rudraraju R; Jones BG; Surman SL; Sealy RE; Thomas PG; Hurwitz JL
PLoS One; 2014; 9(1):e86554. PubMed ID: 24466150
[TBL] [Abstract][Full Text] [Related]
37. Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP.
Trasino SE; Harrison EH; Wang TT
Exp Biol Med (Maywood); 2007 Jun; 232(6):762-71. PubMed ID: 17526768
[TBL] [Abstract][Full Text] [Related]
38. Aldehyde Oxidase Contributes to All-
Zhong G; Seaman CJ; Paragas EM; Xi H; Herpoldt KL; King NP; Jones JP; Isoherranen N
Drug Metab Dispos; 2021 Mar; 49(3):202-211. PubMed ID: 33355213
[TBL] [Abstract][Full Text] [Related]
39. Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification.
Gasimli K; Raab M; Tahmasbi Rad M; Kurunci-Csacsko E; Becker S; Strebhardt K; Sanhaji M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142803
[TBL] [Abstract][Full Text] [Related]
40. TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.
Qi G; Ma H; Li Y; Peng J; Chen J; Kong B
Cell Death Dis; 2021 Dec; 12(12):1135. PubMed ID: 34876569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
